Evidence map›Paper›PMID 20644729›Full record

ArticlePloS one2010

Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo.

Annie Yang, Zhou Zhu, Arminja Kettenbach, Philipp Kapranov, Frank McKeon, Thomas R Gingeras, Kevin Struhl

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Structural diversity of p63 and p73 isoforms.Cell death and differentiation · 2022
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.International journal of molecular sciences · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Annie YangDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Zhou Zhu
Arminja Kettenbach
Philipp Kapranov
Frank McKeon
Thomas R Gingeras
Kevin Struhl
Harvard University · US

Funding

MOLECULAR MECHANISMS OF YEAST TRANSCRIPTIONAL INITIATIONR01GM030186 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STRUHL, KEVIN · 1985 to 2018
$13.6M
Mapping Sites of Transcription and RegulationU01HG003147 · NHGRI · AFFYMETRIX, INC. · PI GINGERAS, THOMAS RAYMOND · 2003 to 2006
$4.1M
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATIONR01CA083944 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MCKEON, FRANK D. · 2000 to 2004
$2.2M
MECHANISMS OF YEAST TRANSCRIPTIONAL INITITATIONR37GM030186 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STRUHL, KEVIN · 1993 to 2002
$2.1M
Epithelial Stem Cell ProgramsR01GM083348 · NIGMS · HARVARD MEDICAL SCHOOL · PI MCKEON, FRANK D. · 2008 to 2011
$1.5M
NCI NIH HHS CA73430NCI NIH HHS CA83944NCI NIH HHS N01 CO012400NCI NIH HHS R01 CA083944NHGRI NIH HHS U01 HG003147NIGMS NIH HHS GM 30186NIGMS NIH HHS R01 GM030186NIGMS NIH HHS R01 GM083348NIGMS NIH HHS R37 GM030186
6 · The paper itself

Abstract

backgroundThe p53 homologs, p63 and p73, share approximately 85% amino acid identity in their DNA-binding domains, but they have distinct biological functions. PRINCIPAL

findingsUsing chromatin immunoprecipitation and high-resolution tiling arrays covering the human genome, we identify p73 DNA binding sites on a genome-wide level in ME180 human cervical carcinoma cells. Strikingly, the p73 binding profile is indistinguishable from the previously described binding profile for p63 in the same cells. Moreover, the p73:p63 binding ratio is similar at all genomic loci tested, suggesting that there are few, if any, targets that are specific for one of these factors. As assayed by sequential chromatin immunoprecipitation, p63 and p73 co-occupy DNA target sites in vivo, suggesting that p63 and p73 bind primarily as heterotetrameric complexes in ME180 cells.

conclusionsThe observation that p63 and p73 associate with the same genomic targets suggest that their distinct biological functions are due to cell-type specific expression and/or protein domains that involve functions other than DNA binding.

Indexed as

Binding SitesCell LineChromatin ImmunoprecipitationDNADNA-Binding ProteinsGenome, HumanGenome-Wide Association StudyHumansNuclear ProteinsPolymerase Chain ReactionProtein BindingTrans-ActivatorsTranscription FactorsTumor Protein p73Tumor Suppressor ProteinsDNADNA-Binding ProteinsNuclear ProteinsTP63 protein, humanTP73 protein, humanTrans-ActivatorsTranscription FactorsTumor Protein p73Tumor Suppressor Proteins

Identifiers

PMID20644729
PMCPMC2904373
OpenAlexW2101585695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.